Oral hypoglycemic drugs for gestational diabetes.
Greene
M F
MF
D001786:Blood Glucose / Q000032:analysis; D000013:Congenital Abnormalities; D016640:Diabetes, Gestational / Q000188:drug therapy*; D005260:Female; D005312:Fetal Blood / Q000737:chemistry; D005320:Fetal Macrosomia; D005905:Glyburide / Q000097:blood / Q000627:therapeutic use*; D006801:Humans; D007004:Hypoglycemic Agents / Q000097:blood / Q000627:therapeutic use*; D007231:Infant, Newborn; D007328:Insulin / Q000097:blood / Q000627:therapeutic use*; D011247:Pregnancy; D011256:Pregnancy Outcome; D013453:Sulfonylurea Compounds / Q000009:adverse effects / Q000627:therapeutic use
D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin; D013453:Sulfonylurea Compounds; D005905:Glyburide